Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

IFF Announces Dr. Casper Vroemen to Succeed Dr. Gregory Yep as Chief R&D and Sustainability Officer


IFF (NYSE: IFF) today announces that Dr. Gregory Yep, Chief R and Sustainability Officer, has resigned effective Sept. 1 to pursue a new opportunity in his professional journey. Yep will be succeeded by Dr. Casper Vroemen—Vice President of R, Health Biosciences—who has dedicated his career to the advancement and commercialization of leading-edge biotechnology. Vroemen will be based in Union Beach, New Jersey, and will become part of IFF’s Executive Leadership Team.

“Through Greg’s leadership, we have established IFF as the go-to partner for science-backed solutions for the health, fragrance, nutrition and home and personal care markets,” said Frank Clyburn, IFF CEO. “We thank Greg for his many contributions, and wish him well in his future endeavors. We have a strong successor in Casper, who will continue to advance our innovation pipeline and sustainability efforts.”

Vroemen joined the Company in 2004 as a scientist and project leader. Over the past two decades, he has assumed roles of increasing responsibility in research and development in Europe and the U.S., and has played a major role in establishing IFF as a bioscience powerhouse. During his tenure, he oversaw the company’s leading position in the protein engineering of industrial enzymes, contributed to the commercialization of multiple new technological advancements, and is a prolific inventor named on many patents.

As Chief R and Sustainability Officer, Vroemen will further IFF’s efforts in innovation, leading the company’s global R strategy, technological development, innovation pipeline and external collaborations. Vroemen holds a Master’s of Science in Molecular Life Sciences and a doctorate in Molecular Biology, both from Wageningen University in the Netherlands.

Welcome to IFF

At IFF (NYSE: IFF)—an industry leader in food, beverage, scent, health and biosciences—science and creativity meet to create essential solutions for a better world. With the beauty of art and the precision of science, we are an international collective of thinkers who partners with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we will do more good for people and planet. Learn more at iff.com, Twitter , Facebook, Instagram, and LinkedIn.

© 2023 by International Flavors Fragrances Inc. IFF is a Registered Trademark. All Rights Reserved.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230803408055/en/

International Flavors & Fragrances Inc. Aktie

88,86 €
0,63 %
Leicht aufwärts geht es heute für die International Flavors & Fragrances Inc. Aktie mit einem Gewinn von 0,63 %.
Bei der Aktie stehen derzeit 18 Buy-Einschätzungen 5 Sell-Einschätzungen gegenüber. Das Sentiment ist also durchaus positiv.
Ein leicht positives Potenzial wird für International Flavors & Fragrances Inc. mit einem Kursziel von 92 € im Vergleich zu 88.86 € gesehen.
Like: 0
Teilen
Business Wire, a Berkshire Hathaway company, is the global leader in press release distribution and regulatory disclosure. Investor relations, public relations, public policy and marketing professionals rely on Business Wire for secure and accurate distribution of market-moving news and multimedia.

Rechtlicher Hinweis

Kommentare